Evidence map›Paper›PMID 31225959›Full record

ArticleAnnals of global health2019

HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions.

Minodora Bianca Ilisiu, Dana Hashim, Trude Andreassen, Nathalie C Støer, Florian Nicula, Elisabete Weiderpass

Abstract read
In one paragraph

Article in Annals of global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Assessing the Level of Knowledge, Beliefs and Acceptance of HPV Vaccine: A Cross-Sectional Study in Romania.International journal of environmental research and public health · 2022
    Article
  15. Article
  16. Article
  17. Challenges in the Prevention of Cervical Cancer in Romania.International journal of environmental research and public health · 2021
    Article
  18. Roma Health: An Overview of Communicable Diseases in Eastern and Central Europe.International journal of environmental research and public health · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Minodora Bianca IlisiuInstitute of Oncology "Prof. Dr. Ion Chiricuţa" of Cluj-Napoca: Prevention and cancer control Center, Cluj-Napoca, RO.
Dana HashimDepartment of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, NO.
Trude AndreassenDepartment of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, NO.
Nathalie C StøerDepartment of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, NO.
Florian NiculaInstitute of Oncology "Prof. Dr. Ion Chiricuţa" of Cluj-Napoca: Prevention and cancer control Center, Cluj-Napoca, RO.
Elisabete WeiderpassDepartment of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, NO.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundRomania has had one of the highest rates of cervical cancer incidence and mortality in Europe for decades. Data on the high-risk human papillomavirus (hrHPV) prevalence within the Romanian population are crucial for cervical cancer intervention in high risk groups. The aim of this study was to determine the prevalence of hrHPV infection in Romania, identifying high-risk areas for cervical cancer prevention efforts.

methodsThe target population of this study were women of all forms in Romania, including ethnic minorities, women from urban and rural areas, and women in various regions. Women with no history of precancerous or cancerous lesions were offered hrHPV screening. The specimens were tested with Hybrid Capture 2 (HC2) DNA test. Age-standardized hrHPV prevalence rates with 95% confidence intervals (CI) were estimated.

resultshrHPV results of 2060 women aged 18 to 70 years were analyzed. The highest hrHPV prevalence rates were observed among: Romanians (17.9%; 95 CI: 15.5-20.7%), Hungarians (16.6%; 95% CI: 13.1-20.8%), Russians (15.6%; 95% CI: 11.3-21.3%), women living in North (19.2%; 95% CI: 16.5-22.3%), and West regions (23.0%; 95 CI: 18.6-28.0%), and women living in urban areas (20.0%; 95 CI: 18.5-28.0%). hrHPV prevalence rates were lower for the Roma population (7.8%; 95% CI: 4.7-12.5%).

conclusionsThese hrHPV prevalence rates in a high cervical cancer incidence country provide baseline information for targeted cervical cancer intervention strategies as well as a baseline to measure the impact of hrHPV vaccination in the future.

Indexed as

AdolescentAdultAgedEarly Detection of CancerFemaleHumansIncidenceMass ScreeningMiddle AgedPapillomavirus InfectionsPrevalenceRomaniaUterine Cervical Neoplasms

Identifiers

PMID31225959
PMCPMC6634611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.